secwatch.observer — SEC 8-K summary
======================================

Issuer:     LUDWIG ENTERPRISES, INC. (LUDG)
CIK:        0001960262
Form:       8-K
Filed at:   2025-05-29T23:59:59+00:00
Accession:  0001213900-25-048524
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ludwig Enterprises publishes ASCO abstract on non-invasive breast cancer mRNA test
--------------------------------------------------------------------------------

- Abstract details mRNA signal from buccal cells combined with machine learning for breast cancer screening.
- Study analyzed 48 mRNA cytokine biomarkers from non-invasive cheek swabs across 40 U.S. clinical centers.
- Top biomarker system achieved F1-score of 0.9, precision 0.892, recall 0.913 (AUC 0.897).
- Second system achieved F1-score of 0.892, precision 0.888, recall 0.902 (AUC 0.849).
- Research presented at ASCO 2025 Annual Meeting; previously under embargo.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1960262/000121390025048524/0001213900-25-048524-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1960262/000121390025048524/ea0243742-8k_ludwig.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-048524

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer